Abstract | BACKGROUND: METHODS: Seventy-four solid-type carcinomas (SCs), 23 ductectatic-type carcinomas (DCs), and specimens of 24 normal pancreata were studied. By histochemical staining, normal duct epithelia, areas of MCH, and carcinomas were classified as having sulfo-type or sialo-type mucus. Foci from normal, DC, SC, sulfo-type, or sialo-type specimens were assessed for K-ras mutation at codon 12 by nested polymerase chain reaction and restriction fragment length polymorphism. RESULTS: Of the SCs, 9 were sulfo-type and 65 were sialo-type; all DC specimens were sialo-type, and all normal epithelia were sulfo-type. All foci of sulfo-type, nonneoplastic epithelia were negative for K-ras mutation. In contrast, 124 of 313 sialo-type MCH foci (40%) had a K-ras mutation. Of 74 SCs, only 3 of 9 sulfo-type tumors (33%) were positive for the mutation. Sixty of 65 sialo-type SCs (92%) had a K-ras mutation, whereas 15 of 23 sialo-type DCs (65%) had a mutation. K-ras mutant carcinomas (including both SCs and DCs) were associated with K-ras mutant MCH in 109 of 198 MCHs (55%), whereas carcinomas without a K-ras mutation had mutations in 6 of 68 MCHs (9%). MCH in normal pancreata revealed K-ras mutations in 9 of 51 foci (18%). In addition, in K-ras mutant carcinomas, frequency of K-ras mutation in MCH increased from 27% (11 of 41 foci) of nonpapillary MCHs to 62% (98 of 157 foci) of papillary MCHs; but in K-ras wild-type carcinoma, the mutation rate in MCH was unchanged from 12% (3 of 26 foci) to 7% (3 of 42 foci) in nonpapillary and papillary foci, respectively. CONCLUSIONS: These results suggest a strong relationship between the risk of pancreatic carcinoma and the presence of combinations of K-ras gene mutation, papillary growth, and expression of sialomucin in foci of MCH.
|
Authors | H Matsubayashi, H Watanabe, K Nishikura, Y Ajioka, H Kijima, T Saito |
Journal | Cancer
(Cancer)
Vol. 82
Issue 4
Pg. 651-60
(Feb 15 1998)
ISSN: 0008-543X [Print] United States |
PMID | 9477096
(Publication Type: Journal Article)
|
Chemical References |
- DNA, Neoplasm
- Mucins
- HRAS protein, human
- Proto-Oncogene Proteins p21(ras)
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Ductal, Breast
(genetics, metabolism, pathology)
- DNA, Neoplasm
(analysis)
- Female
- Genes, ras
(genetics)
- Humans
- Hyperplasia
(genetics, metabolism, pathology)
- Male
- Middle Aged
- Mucins
(metabolism)
- Mucous Membrane
(metabolism, pathology)
- Pancreatic Ducts
(metabolism, pathology)
- Pancreatic Neoplasms
(genetics, metabolism, pathology)
- Phenotype
- Point Mutation
- Polymerase Chain Reaction
- Proto-Oncogene Proteins p21(ras)
(metabolism)
|